BSG

Basigin · P35613 · BSG on Sugi Atlas →

18 patent compounds predicted against BSG, 3 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
Pseudolaric Acid B Pseudolaric Acid B (SCHEMBL16426061) 0.58 1/20
Pseudolaric Acid B Pseudolaric Acid B (SCHEMBL29357444) 0.58 1/20
Pseudolaric Acid B Pseudolaric Acid B (SCHEMBL29367226) 0.58 1/20

Clinical trials — most relevant to BSG by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Clinical Research of Licartin Combined With TACE in the Treatment of Unresectable Hepatocellular Carcinoma PHASE4COMPLETED
Effect of Dexmedetomidine and Total Intravenous Anesthesia on Endothelial Damage-Related Biomarkers PHASE4COMPLETED
Study to Assess the Effect of Meplazumab on COVID-19 PHASE2/PHASE3COMPLETED
Targeting the Endothelial Glycocalyx to Enhance Vascular Function and Exercise-Induced Vascular Adaptations in Type 2 Diabetes PHASE2/PHASE3COMPLETED
Open-Label Study to Assess Meplazumab in Adult Patients Diagnosed with Plasmodium Falciparum PHASE2ACTIVE_NOT_RECRUITING
CD22 Targeting CAR-T Therapy Against B Cell Hematological Malignancies PHASE1/PHASE2UNKNOWN
Polymer-lipid Particle-delivered CAR1920 mRNA CAR-T Therapy for Relapsed/Refractory B-cell Lymphoma/Leukemia PHASE2RECRUITING
A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies PHASE1/PHASE2UNKNOWN
A Study of CD147-targeted CAR-T by Hepatic Artery Infusions for Very Advanced Hepatocellular Carcinoma PHASE1UNKNOWN
CD147-CAR T Cells for Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma EARLY_PHASE1UNKNOWN
Diagnostic Study of Combined Biomnarker Testing in Bronchoalveolar Lavage Samples of Immunocompromised Patients nanUNKNOWN
Assessment of the 1-year Relapse Rate in Patients with Pemphigus Treated According to the Revised Pemphigus PNDS nanCOMPLETED
Immunoglobulin for Hypogammaglobulinemia Due to Chimeric Antigen Receptor T Cell Therapy nanRECRUITING
Bioelectrical Impedance in Monitoring Hyperhydration and Polyneuromyopathy in Critically Ill Patients nanCOMPLETED
Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes nanCOMPLETED
Identification of Donors of CD36-Deficient Platelets Among Japanese Individuals on the NIH Campus nanCOMPLETED
Perioperative Plasma Levels of Glycocalyx Markers in Colon Surgery. nanUNKNOWN
Presepsin:Gelsolin Ratio in Sepsis-related Organ Dysfunction nanCOMPLETED
Biomarkers of Lichen Sclerosus nanUNKNOWN
Sclerostin and Vascular Calcification in CKD and Renal Transplant nanUNKNOWN
Characterization of Proteoglycan Depletion in Femoroacetabular Impingement With T1ρ Magnetic Resonance Imaging (MRI) nanCOMPLETED
Glycan Attachment Specificity, Toward ROtavirus Vaccine IMprovement GASTROVIMc (Clinical Investigation) nanCOMPLETED
Evaluation of Desmoglein-3 Autoantibodies in the Tissues of Oral Lichen Planus and Correlation with Disease Severity nanNOT_YET_RECRUITING
Expression of CD19 Complex in Lymphoproliferative Disorders nanUNKNOWN
Endothelial Dysfunction and Selenium Status in Children With Acute Systemic Inflammatory Response nanCOMPLETED
Thymoglobulin: Presence and Affect in the Central Lymphatic Compartment nanCOMPLETED
sCD163 in HELLP Syndrome nanNOT_YET_RECRUITING
Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis. nanRECRUITING
CHT105 for the Treatment of Refractory Lupus Nephritis nanENROLLING_BY_INVITATION
Pharmacokinetics of Low Molecular Weight Heparin in Cancer Patients nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a BSG binder may also engage these)

ProteinNameSimilarity
P17790 0.991 P17790 →
P18572 0.989 P18572 →
P26453 0.987 P26453 →
Q28740 0.981 Q28740 →
Q66KX2 0.978 Q66KX2 →
Q7ZXX1 0.976 Q7ZXX1 →
Q2WGK2 0.975 Q2WGK2 →
Q6DJ83 0.974 Q6DJ83 →
Q8IZU9 0.973 Q8IZU9 →
Q8BR86 0.973 Q8BR86 →
A3KPA0 0.973 A3KPA0 →
Q32MD9 0.972 Q32MD9 →
Q99PA3 0.972 Q99PA3 →
Q68FQ2 0.971 Q68FQ2 →
Q1WIM2 0.971 Q1WIM2 →
Q4KMG0 0.971 Q4KMG0 →
Q9BX67 0.971 Q9BX67 →
Q99N28 0.971 Q99N28 →
Q8N3J6 0.971 Q8N3J6 →
Q0PMG2 0.971 Q0PMG2 →
O94985 0.970 O94985 →
Q9Y624 0.970 Q9Y624 →
Q865R3 0.969 Q865R3 →
L1CAM Neural cell adhesion molecule L1 0.969 landscape →
Q1WIM3 0.969 Q1WIM3 →
O88792 0.969 O88792 →
Q9D8B7 0.968 Q9D8B7 →
Q6PE55 0.968 Q6PE55 →
Q2PFX1 0.968 Q2PFX1 →
O35158 0.968 O35158 →